Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's Disease: Combined Low Inflammatory-index Diet, Physical Exercises, and Cognitive Training in Nursing Home

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study is a multicentre, randomized, double-blind, controlled trial that aims to investigate the efficacy of multi-domain life-style intervention including low inflammatory-index diet, exercise, and cognitive training in patients with mild cognitive impairment and mild Alzheimer's disease.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 60
Maximum Age: 90
Healthy Volunteers: f
View:

• Aged 60-90 years

• In accordance with the diagnostic criteria for mild cognitive impairment due to Alzheimer's disease or mild Alzheimer's disease from the National Institutes of Health National Institute on Aging-Alzheimer's Association (NIA-AA) (2011)

• The Hamilton depression rating scale/17 edition (HAMD) total score≤10

• Neurological examination: no obvious signs

• Education: primary school (grade 6) or above and capacity to complete tests for cognitive ability

• Capacity to give consent

Locations
Other Locations
China
Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine
RECRUITING
Shanghai
Contact Information
Primary
Binyin Li, Dr
lby11917@rjh.com.cn
021-64370045
Time Frame
Start Date: 2023-05-11
Estimated Completion Date: 2026-08-30
Participants
Target number of participants: 180
Treatments
Experimental: Multi-domain intervention group
Patients in this arm will receive multi-domain life-style intervention including low inflammatory-index diet, exercise, and cognitive training.
Experimental: Exercise and cognitive training
Patients in this arm will receive the intervention of exercise and cognitive training.
No_intervention: Standard health counseling at baseline
Patients in this arm will have their habitual diet and life style. No particular intervention or consultation would be provided.
Related Therapeutic Areas
Sponsors
Leads: Ruijin Hospital
Collaborators: Shanghai Sinopharm Nursing Care Center

This content was sourced from clinicaltrials.gov

Similar Clinical Trials